Abstract:The purpose of this study was to develop and evaluate a novel amorphous solid dispersion system for tectorigenin (TG). TG is one of isoflavone aglycones extracted from Iris tectorum and flowers of Pueraria thunbergiana , but its poor water solubility and low membrane permeability have severely restricted the clinical application. To increase the aqueous solubility and oral bioavailability of TG, we prepared the solid dispersions of tectorigenin (TG-SD) using a simple solvent evaporation process with TG, polyvinylpyrrolidone (PVP) and PEG4000 at weight ratio of 7:54:9 after tested in several ratios. The prepared solid dispersions of tectorigenin are duly characterized for drug morphological conversion, in vitro dissolution and in vivo bioavailability. The X-ray diffraction (XRD), differential scanning calorimetry (DSC) and scanning electron microscopy (SEM) studies have indicated the morphological conversion of tectorigenin to amorphous form. In vitro release profiles revealed that the % release of TG-SD was achieved 4.35-fold higher than that of the pure drug after 150 min. The oral bioavailability of the solid dispersion in rats was also increased based on AUC 0–t and C max of TG-SD, which were 4.8- and 13.1-fold higher than that of TG crystal, respectively. It is worth noting that physical mixture containing TG, PEG 4000 and PVP produced a similar level of oral exposure as TG-SD, suggesting that PEG 4000 and PVP were able to enhance bioavailability of TG in rats. However, with the reduction of particle size, TG-SD provided the fastest oral absorption compared to physical mixture and pure drug. These results demonstrated that the efficacy of solid dispersions for the enhancement of TG oral bioavailability was by increasing its aqueous solubility and the solid dispersion formulation could be a viable option for enhancing the oral bioavailability of TG.

Development and in-vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique.

Enhanced Oral Bioavailability of Oligomeric Proanthocyanidins by a Self-Double-emulsifying Drug Delivery System

Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement.

Preparation of oridonin-loaded solid lipid nanoparticles and studies on them in vitro and in vivo

In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.

Study of a Novel Disintegrable Oleanolic Acid-Polyvinylpolypyrrolidone Solid Dispersion

In-Vitro Characterization And Oral Bioavailability Of Organic Solvent-Free Solid Dispersions Containing Telmisartan

Preparation, Characterization and Evaluation of Nintedanib Amorphous Solid Dispersions with Enhanced Oral Bioavailability

Facile preparation of solid dispersions by dissolving drugs in <i>N</i>-vinyl-2-pyrrolidone and photopolymerization

Synthesis, characterization, in vitro and in vivo evaluation of PEGylated oridonin conjugates.

Enhanced Dissolution and Oral Bioavailability of Valsartan Solid Dispersions Prepared by a Freeze-Drying Technique Using Hydrophilic Polymers

Optimization and Evaluation of Oridonin-loaded Soluplus®-Pluronic P105 Mixed Micelles for Oral Administration

Studies on Preparation and in Vitro and in Vivo Evaluation of Docetaxel Solid Dispersion

In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers

Preparation, Characterization and in Vitro Evaluation of Solid Dispersions Containing Docetaxel

In Vitro Dissolution and Physicochemical Characterizations of Novel PVP-based Solid Dispersions Containing Valsartan Prepared by a Freeze-Drying Method.

Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability

Preparation And Characteristics Of Oridonin-Loaded Nanostructured Lipid Carriers As A Controlled-Release Delivery System

Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.

Improvement in Oral Bioavailability and Dissolution of Tanshinone IIA by Preparation of Solid Dispersions with Porous Silica

Studies on the Oridonin-Loaded Poly(d,l-Lactic Acid) Nanoparticles in Vitro and in Vivo